The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Sustained Hemodynamic Effects of Intravenous Levosimendan
Abstract
Background— The short-term infusion of levosimendan (Levo) improves hemodynamic function in patients with decompensated heart failure. The metabolites of Levo have a prolonged half-life, and one is hemodynamically active. The goal of this study was to determine whether the hemodynamic effects of Levo are sustained during a long-term infusion and beyond the discontinuation of drug infusion. Methods and Results— Patients with decompensated heart failure received escalating infusion rates of intravenous Levo (n=98) or placebo (n=48) for 6 hours. At the end of 6 hours, 85 of the Levo-treated patients were continued on open-label drug for a total of 24 hours, at which time they were randomized 1:1 to an additional 24 hours of Levo (n=43) or placebo (n=42).The hemodynamic effects observed at 24 hours were maintained at 48 hours in both the continuation and withdrawal groups and did not differ between groups. Although the plasma concentration of Levo decreased rapidly in the withdrawal group, concentrations of the active metabolite OR-1896 were similar in the continuation and withdrawal groups at 24 hours and increased further (3.5-fold to 4-fold) and to a similar extent in both groups at 48 hours. Conclusions— The hemodynamic effects of Levo were maintained during a 48-hour continuous infusion and for at least 24 hours after discontinuation of a 24-hour infusion. The active metabolite OR-1896 increased for at least 24 hours after cessation of drug infusion and may account for the prolonged hemodynamic effects of Levo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Follath, F., Cleland, J., Just, H., Papp, J., Scholz, H., Peuhkurinen, K., Harjola, V., Mitrovic, V, Abdalla, M., Sandell, E.-P., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09455-2 · Cited by 1,185
Self-citationMoiseyev, V (2002) · European Heart Journal · doi:10.1053/euhj.2001.3158 · Cited by 595
Acute Hemodynamic and Clinical Effects of Levosimendan in Patients With Severe Heart Failure
Slawsky, M. T., Colucci, W. S., Gottlieb, S. S., Greenberg, B. H., Haeusslein, E., Hare, J., Hutchins, S., Leier, C. V., LeJemtel, T. H., Loh, E., et al. (2000) · Circulation · doi:10.1161/01.cir.102.18.2222 · Cited by 478
Self-citationCardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan
Haikala, H. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(95)90009-8 · Cited by 304
Yokoshiki, H., Katsube, Y., Sunagawa, M., & Sperelakis, N. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01108-4 · Cited by 299
Pollesello, P., Ovaska, M., Kaivola, J., Tilgmann, C., Lundström, K., Kalkkinen, N., Ulmanen, I., Nissinen, E., & Taskinen, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61945-9 · Cited by 232
Cited by
Packer, M., Colucci, W., Fisher, L., Massie, B. M., Teerlink, J. R., Young, J., Padley, R. J., Thakkar, R., Delgado-Herrera, L., Salon, J., et al. (2013) · JACC: Heart Failure · doi:10.1016/j.jchf.2012.12.004 · Cited by 436
Self-citationCunha-Goncalves, D., Perez-de-Sa, V., Larsson, A., Thörne, J., & Blomquist, S. (2009) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181af40e0 · Cited by 24
Metadata
- Authors
- Kivikko, M., Lehtonen, L., & Colucci, W. S.
- Venue
- Circulation
- Published
- 2003-01-07
- Volume
- 107
- Issue
- 1
- Pages
- 81-86
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2029377396
- Cited by
- 258
- References
- 6
- FWCI
- 16.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sustained Hemodynamic Effects of Intravenous Levosimendan. https://app.cochat.ai/papers/10.1161/01.cir.0000043245.00859.11
- The paper
- Kivikko, M., Lehtonen, L., & Colucci, W. S. (2003). Sustained Hemodynamic Effects of Intravenous Levosimendan. Circulation. https://doi.org/10.1161/01.cir.0000043245.00859.11
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.